In 1996 was created Alternative Investments Group, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Southport.
The usual cause for the fund is to invest in rounds with more than 10 partakers. Despite the Alternative Investments Group, startups are often financed by Scottish Equity Partners, Excalibur Fund Managers. The meaningful sponsors for the fund in investment in the same round are UOB Venture, Temasek Holdings, Societe Generale Asset Management. In the next rounds fund is usually obtained by Scottish Equity Partners.
This organization was formed by Flinn Flexer. Besides them, we counted 9 critical employees of this fund in our database.
Among the most successful fund investment fields, there are Pharmaceutical, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Cyclacel Pharmaceuticals For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2004. The higher amount of exits for fund were in 2006. The fund is constantly included in less than 2 deals per year.
Related Funds
Funds with similar focus
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.